Jefferies Financial Group Inc. Raises Stock Position in Maximus, Inc. $MMS

Jefferies Financial Group Inc. increased its holdings in Maximus, Inc. (NYSE:MMS) by 453.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 60,361 shares of the health services provider’s stock after acquiring an additional 49,461 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Maximus were worth $5,210,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the business. Farther Finance Advisors LLC grew its stake in shares of Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 116 shares during the last quarter. Advisory Services Network LLC purchased a new position in shares of Maximus in the 3rd quarter valued at approximately $32,000. Canada Pension Plan Investment Board purchased a new position in shares of Maximus in the 2nd quarter valued at approximately $35,000. Cullen Frost Bankers Inc. purchased a new position in shares of Maximus in the 3rd quarter valued at approximately $38,000. Finally, Richardson Financial Services Inc. grew its stake in shares of Maximus by 29.6% in the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 103 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Price Performance

Shares of NYSE MMS opened at $61.09 on Tuesday. The stock has a market cap of $3.21 billion, a price-to-earnings ratio of 9.15 and a beta of 0.60. Maximus, Inc. has a 52 week low of $56.92 and a 52 week high of $100.00. The company’s 50-day moving average price is $65.26 and its 200 day moving average price is $77.89. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87.

Maximus (NYSE:MMS) last released its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The firm’s quarterly revenue was down 4.1% on a year-over-year basis. During the same period in the prior year, the firm earned $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, research analysts forecast that Maximus, Inc. will post 8.4 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Friday, May 15th. Maximus’s dividend payout ratio is presently 19.76%.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 742 shares of the stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the transaction, the director directly owned 20,795 shares in the company, valued at $1,502,438.75. This represents a 3.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.80% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Finally, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Maximus currently has a consensus rating of “Hold”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.